Activiteiten
2023
Transition towards human-based safety assessment of chemicals: An integrated innovation system framework for analysing New ApproachMethodologiesHoekman, J. (Presenter)
14 Jun 2023 → 16 Jun 2023
, Eu-SPRI 2023 Conference2022
EU-SPRI Conference 2022Hoekman, J. (Organiser)
1 Jun 2022 → 3 Jun 2022
2021
DRUID Conference 2021Hoekman, J. (Participant)
20 Oct 2021
2019
Innovation in distributed forms of drug manufacturing: the case of in-hospital production of medicinesHoekman, J. (Presenter)
13 Dec 2019
, Annual International Workshop on Medical Innovation (WOMI) 2019Same risks or same organizing processes? Constructing similarity in the risk profiles of innovative productsHoekman, J. (Presenter)
12 Dec 2019
, Annual International Workshop on Medical Innovation (WOMI) 2019Emerging risks over the technological life-cycle: An analysis of pharmaceutical innovationHoekman, J. (Speaker)
21 Jun 2019
, DRUID Society Conference 20192018
Workshop on Medical InnovationHoekman, J. (Organiser)
13 Dec 2018 → 14 Dec 2018
Searching for side-effects: experiential learning about risks over the technological life-cycleHoekman, J. (Speaker)
12 Dec 2018 → 14 Dec 2018
, Annual International Workshop on Medical Innovation (WOMI)Reproducibility in scienceHoekman, J. (Lecturer)
5 Nov 2018
, Research Integrity Training PhD Graduate School GeosciencesLecture on understanding drug regulationHoekman, J. (Speaker)
10 Jul 2018
Searching for side-effects: how knowledge on drug risks accumulates over the product life-cycleHoekman, J. (Speaker)
18 Jun 2018 → 20 Jun 2018
, 27th Annual Conference of the Society for Risk Analysis EuropeTowards distributed drug innovationHoekman, J. (Speaker)
14 Jun 2018 → 16 Jun 2018
, 7th STS Italia Conference Advisory session on tools to extract data from drug labelsHoekman, J. (Advisor)
17 May 2018
Are artifacts with exaptation potential riskier?Hoekman, J. (Speaker)
26 Apr 2018 → 28 Apr 2018
, second international conference on exaptation and inverse-question driven innovation2017
Stakeholder experience with expedited programs: process-related issuesHoekman, J. (Invited speaker)
7 Jun 2017
, International Harmonization of Expedited Programs2015
The 24th Society for Risk Analysis Europe Conference (SRA), Science, Policy and Society Bridging the gap between risk and science, MaastrichtHoekman, J. (Invited speaker)
15 Jun 2015 → 17 Jun 2015
, The 24th Society for Risk Analysis Europe Conference (SRA), Science, Policy and Society Bridging the gap between risk and science, MaastrichtUse of the conditional marketing authorisation pathway for oncology drugsHoekman, J. (Invited speaker)
2015
Use of the conditional marketing authorisation pathway for oncology drugsHoekman, J. (Invited speaker)
2015
Use of the conditional marketing authorisation pathway for oncology drugsHoekman, J. (Invited speaker)
2015
European Commission (External organisation)Hoekman, J. (Member)
2015
2014
30th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Taipei, TaiwanHoekman, J. (Invited speaker)
24 Oct 2014 → 27 Oct 2014